|Articles|October 1, 2015
- BioPharm International-10-01-2015
- Volume 28
- Issue 10
BioPharm International, October 2015 Issue (PDF)
Click the title above to open the BioPharm International October 2015 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 10 years ago
A Review of Glycan Analysis Requirementsover 10 years ago
Evolving to Meet Industry Changesover 10 years ago
Small-Molecule API CMOs Are Thrivingover 10 years ago
Small-Scale and At-Scale Model Development and Optimizationover 10 years ago
Market Access in ChinaNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
4
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
5
